Marc O’Connor

The summit provides a place for specialty pharmacy stakeholders to discuss the industry.

Tips for specialty pharmacy and manufacturer representatives on effectively leveraging your time at the annual Asembia Specialty Pharmacy Summit.

Specialty pharmacies that offer effective medication therapy management and support are best suited to serve as arbiters of the next generation of value-based contracts.

Payers, providers, manufacturers, and patients will need to navigate a complicated landscape in the shift to value-based health care.

As with care for any chronic condition, the goals for advanced oncology therapies should be improving outcomes, containing costs, and increasing medication adherence.

The Affordable Care Act has created a glut of patients awaiting authorization for the therapies payers have longed for.

Specialty pharmacies could serve as the primary conduit to generate value from at-risk agreements between manufacturers and providers.

Value and outcomes are key considerations when seeking to reduce health care costs.

The support of specialty pharmacy can facilitate patient access to this new class of drugs for the treatment of high cholesterol.

A clinic sees improved viral suppression rates as a result of comprehensive medication review, medication synchronization, and patient outreach services.